For end-stage retinopathy, vitrectomy will also remain ... GH inhibitors, corticosteroids (triamcinolone acetonide, fluocinolone acetonide and dexamethasone), intravitreal injections of anti ...
Treating diabetic retinopathy (DR) is still a significant challenge for clinicians and remains a leading cause of blindness worldwide. NovaGo Therapeutics is developing a human antibody therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback